Literature DB >> 9422626

The risk and complications of aspiration following cricopharyngeal myotomy.

B H Campbell1, T C Tuominen, R J Toohill.   

Abstract

This article reviews a series of patients undergoing cricopharyngeal myotomy and determines whether clinically dangerous aspiration is seen postoperatively. A total of 23 patients underwent myotomy. Indications included Zenker's diverticulum (14), anticipated or real dysphagia from skull base lesions (5), dysphagia from stroke (2), and dysphagia from glossectomy and radiation therapy (2). Surgical procedures, complications, and effectiveness were reviewed. Of patients with Zenker's diverticula, 13 of 14 had clinically useful improvement in dysphagia. Of patients with skull base lesions, all 5 had improvement (4 of these also had thyroplasites and cervical plexus-to-superior laryngeal nerve anastomoses). Of the patients with strokes, neither had significant improvement. Of the patients with glossectomy and radiation, 1 had useful improvement. Complications were seen in 5 patients: 2 had self-limiting pharyngeal leaks, and 3 had pneumonia 1-4 months postoperatively. One patient also had a postoperative ipsilateral recurrent laryngeal nerve injury. There were no postoperative deaths. In conclusion, cricopharyngeal myotomy has definite utility in the management of cervical dysphagia, even though the etiology of the dysphagia can be multifactorial. Risks directly attributable to the procedure are usually self-limiting; serious complications are usually associated with the underlying disease. The addition of adjunctive procedures, such as thyroplasty and superior laryngeal nerve reinnervation, may be of additional benefit to patients with high extracranial vagal injuries.

Entities:  

Mesh:

Year:  1997        PMID: 9422626     DOI: 10.1016/s0002-9343(97)00325-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Endoscopic balloon catheter dilation for treatment of primary cricopharyngeal dysfunction.

Authors:  Sergio Zepeda-Gómez; Aldo Montaño Loza; Francisco Valdovinos; Max Schmulson; Miguel A Valdovinos
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

2.  Speech pathologist practice patterns for evaluation and management of suspected cricopharyngeal dysfunction.

Authors:  Corinne A Jones; Molly A Knigge; Timothy M McCulloch
Journal:  Dysphagia       Date:  2014-02-06       Impact factor: 3.438

3.  European white paper: oropharyngeal dysphagia in head and neck cancer.

Authors:  Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-12-19       Impact factor: 2.503

4.  Cricopharyngeal muscle origin transection for oropharyngeal dysphagia, a novel surgical technique.

Authors:  Hideaki Kanazawa; Ichiro Fujishima; Tomohisa Ohno; Kenjiro Kunieda; Takashi Shigematsu; Masanaga Yamawaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-12       Impact factor: 3.236

5.  Dysphagia.

Authors:  Dawn D. F. Ferguson; Kenneth R. DeVault
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08

Review 6.  Dysphagia in Lateral Medullary Syndrome: A Narrative Review.

Authors:  Sung Ho Jang; Min Son Kim
Journal:  Dysphagia       Date:  2020-07-11       Impact factor: 3.438

7.  Persistent post-stroke dysphagia treated with cricopharyngeal myotomy.

Authors:  Sruthi S Nair; Arathy Jalaja Surendaran; Jayakumar R Menon; Sapna Erat Sreedharan; Padmavathy N Sylaja
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.